Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

StemCells Company Profile (NASDAQ:STEM)

Consensus Ratings for StemCells (NASDAQ:STEM) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $7.00 (495.74% upside)

Analysts' Ratings History for StemCells (NASDAQ:STEM)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/7/2014Maxim GroupInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
7/2/2014Brinson PatrickInitiated CoverageOutperform$7.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2014Maxim GroupBoost Price TargetBuy$2.50 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
6/17/2014Chardan CapitalReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
5/19/2014Maxim GroupReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Edison Investment ResearchNeutralViewTweet This Rating  Share This Rating on StockTwits
11/12/2012Ascendiant Capital MarketsLower Price TargetBuy$2.60 -> $2.25ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss StemCells